Piperidinyl and piperazinyl compounds substituted with bicyclo-heterocyclylalkyl groups useful as CCR3 receptor antagonists
申请人:Gong Leyi
公开号:US20050090504A1
公开(公告)日:2005-04-28
Compounds having the Formula (I),
are useful as CCR3 receptor antagonists, wherein Ar is aryl or heteroaryl; Q is —C(═O)— or C
1-2
alkylene; X is N(
+
)R
9a
, or N; Y is CR
9b
, or N; R
2
is hydrogen or alkyl; R
3
and R
4
are as defined in the specification; U
c
is a mono- or bicyclic group as defined in the specification; n is 0 or 1; and p is 0, 1, 2, 3 or 4.
具有化学式(I)的化合物,作为CCR3受体拮抗剂是有用的,其中Ar是芳基或杂环芳基;Q是—C(═O)—或C1-2烷基;X是N(+)R9a,或N;Y是CR9b,或N;R2是氢或烷基;R3和R4如规范中所定义;Uc是如规范中定义的单环或双环基团;n为0或1;p为0, 1, 2, 3或4。